Institutional Sign In

Go

Bayer Czech Republic

Bayer CR's Cash & Cash Equivalents rose 94.1% yoy to CZK 10.8 mil in 2017

By Helgi Library - April 2, 2020

Bayer Czech Republic's total assets reached CZK 1,165 mil at the end of 2017, down 3.71% compared to the previous year. ...

Bayer CR's Cash & Cash Equivalents rose 94.1% yoy to CZK 10.8 mil in 2017

By Helgi Library - April 2, 2020

Bayer Czech Republic's total assets reached CZK 1,165 mil at the end of 2017, down 3.71% compared to the previous year. ...

Profit Statement
Balance Sheet
Ratios
Cash Flow

Get all company financials in excel:

Download Sample   $19.99

Get all company financials in excel:

Download Sample   $19.99

Bayer, s.r.o. (or Bayer Czech Republic in our case) is a Czech Republic-based subsidiary of Bayer AG, the German chemical and pharmaceutical company founded in Barmen, Germany in 1863. It is headquartered in Leverkusen, North Rhine-Westphalia, Germany and well known for its original brand of aspirin. The Company is now a global enterprise with core competencies in the fields of health care, agriculture and high-tech polymer materials. In fiscal year 2013, Bayer employed 113,200 people and had sales of EUR 40.2 bil.

Bayer Czech Republic Logo

Finance

Bayer Czech Republic has been growing its sales by a year on average in the last 5 years. EBITDA has grown on average by 7.04% a year during that time to total of CZK 158 mil in 2017, or 3.77% of sales. That’s compared to 4.11% average margin seen in last five years.

The company netted CZK 106 mil in 2017 implying ROE of 27.2% and ROCE of 10.4%. Again, the average figures were 41.9% and 23.7%, respectively when looking at the previous 5 years.

Bayer Czech Republic’s net debt amounted to CZK 393 mil at the end of 2017, or 94.4% of equity. When compared to EBITDA, net debt was 2.49x, up when compared to average of 1.13x seen in the last 5 years.